CTNNB1 and colorectal cancer: Further in-vitro experiments suggested that CLCA1 may function as a tumor suppressor in colorectal cancer by inhibiting the Wnt/beta-catenin signaling pathway and epithelial-mesenchymal transition, while in-vivo overexpression of CLCA1 led to inhibition of proliferation and metastasis [14].